8 States Probe Abbott's Marketing Of Anti-Seizure Drug

Law360, New York (February 21, 2012, 8:27 PM EST) -- Abbott Laboratories Inc., already facing a U.S. Department of Justice investigation over Depakote, disclosed Tuesday that the attorneys general of eight states are investigating whether the company's promotion of improper off-label uses for the anti-seizure drug Depakote violated state laws.

The attorneys general of Florida, Illinois, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina and Texas have formed a committee on behalf of themselves and other state attorneys general to investigate possible state law violations in Abbott's sales and marketing activities for Depakote, according to Abbott's annual...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.